Royce & Associates’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-59,009
| Closed | -$476K | – | 901 |
|
2024
Q3 | $476K | Hold |
59,009
| – | – | ﹤0.01% | 803 |
|
2024
Q2 | $500K | Hold |
59,009
| – | – | ﹤0.01% | 787 |
|
2024
Q1 | $529K | Hold |
59,009
| – | – | ﹤0.01% | 788 |
|
2023
Q4 | $663K | Hold |
59,009
| – | – | 0.01% | 773 |
|
2023
Q3 | $509K | Hold |
59,009
| – | – | 0.01% | 811 |
|
2023
Q2 | $611K | Hold |
59,009
| – | – | 0.01% | 813 |
|
2023
Q1 | $640K | Hold |
59,009
| – | – | 0.01% | 819 |
|
2022
Q4 | $662K | Hold |
59,009
| – | – | 0.01% | 798 |
|
2022
Q3 | $598K | Hold |
59,009
| – | – | 0.01% | 798 |
|
2022
Q2 | $535K | Hold |
59,009
| – | – | 0.01% | 827 |
|
2022
Q1 | $564K | Hold |
59,009
| – | – | ﹤0.01% | 869 |
|
2021
Q4 | $652K | Hold |
59,009
| – | – | ﹤0.01% | 857 |
|
2021
Q3 | $437K | Hold |
59,009
| – | – | ﹤0.01% | 916 |
|
2021
Q2 | $857K | Hold |
59,009
| – | – | 0.01% | 866 |
|
2021
Q1 | $1.2M | Hold |
59,009
| – | – | 0.01% | 830 |
|
2020
Q4 | $1.05M | Sell |
59,009
-34,291
| -37% | -$610K | 0.01% | 809 |
|
2020
Q3 | $1.38M | Hold |
93,300
| – | – | 0.01% | 737 |
|
2020
Q2 | $1.96M | Hold |
93,300
| – | – | 0.02% | 670 |
|
2020
Q1 | $2.16M | Hold |
93,300
| – | – | 0.03% | 574 |
|
2019
Q4 | $2.42M | Hold |
93,300
| – | – | 0.02% | 664 |
|
2019
Q3 | $1.82M | Hold |
93,300
| – | – | 0.02% | 721 |
|
2019
Q2 | $1.52M | Hold |
93,300
| – | – | 0.01% | 774 |
|
2019
Q1 | $2.12M | Hold |
93,300
| – | – | 0.02% | 732 |
|
2018
Q4 | $2.39M | Hold |
93,300
| – | – | 0.02% | 678 |
|
2018
Q3 | $3.05M | Hold |
93,300
| – | – | 0.02% | 723 |
|
2018
Q2 | $2.12M | Hold |
93,300
| – | – | 0.01% | 826 |
|
2018
Q1 | $2.26M | Hold |
93,300
| – | – | 0.02% | 815 |
|
2017
Q4 | $2.6M | Hold |
93,300
| – | – | 0.02% | 781 |
|
2017
Q3 | $3.2M | Hold |
93,300
| – | – | 0.02% | 719 |
|
2017
Q2 | $3.72M | Sell |
93,300
-10,000
| -10% | -$398K | 0.02% | 683 |
|
2017
Q1 | $3.8M | Hold |
103,300
| – | – | 0.02% | 673 |
|
2016
Q4 | $3.29M | Sell |
103,300
-15,500
| -13% | -$494K | 0.02% | 691 |
|
2016
Q3 | $4.31M | Sell |
118,800
-146,900
| -55% | -$5.32M | 0.03% | 640 |
|
2016
Q2 | $6.03M | Sell |
265,700
-97,000
| -27% | -$2.2M | 0.04% | 534 |
|
2016
Q1 | $6.82M | Sell |
362,700
-45,900
| -11% | -$863K | 0.04% | 510 |
|
2015
Q4 | $6.7M | Sell |
408,600
-105,100
| -20% | -$1.72M | 0.04% | 535 |
|
2015
Q3 | $5.65M | Buy |
513,700
+27,000
| +6% | +$297K | 0.03% | 613 |
|
2015
Q2 | $6.34M | Sell |
486,700
-19,200
| -4% | -$250K | 0.03% | 670 |
|
2015
Q1 | $8.78M | Sell |
505,900
-68,500
| -12% | -$1.19M | 0.03% | 622 |
|
2014
Q4 | $8.57M | Buy |
574,400
+479,400
| +505% | +$7.15M | 0.03% | 649 |
|
2014
Q3 | $2.19M | Sell |
95,000
-6,228
| -6% | -$144K | 0.01% | 990 |
|
2014
Q2 | $3.23M | Buy |
+101,228
| New | +$3.23M | 0.01% | 952 |
|